BSPM [Biostar Pharmaceuticals] 10-Q: FORM 10-Q (Mark One) x March 31, 2014

[FORM 10-Q (Mark One) x March 31, 2014 For the quarterly period ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 011-86-29-33686638 (Former name, former] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this quarterly 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period] [CERTIFICATION I, Qinghua Liu, certify that: 1. I have reviewed this quarterly 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Ronghua Wang Chief Executive Officer EX-32.1 4 ex32-1.htm EX-32.1] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Qinghua Liu, Interim Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 ex32-2.htm EX-32.2]

By | 2016-03-28T18:32:00+00:00 May 15th, 2014|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMA] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x March 31, 2014 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC Nevada 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86- 898-6681-1730 (China) (Issuer's telephone number, including area code)] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: May 15, 2014 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qex321033114.htm]

By | 2016-03-28T19:38:04+00:00 May 15th, 2014|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMA] 10-Q: FORM 10-Q (Mark One) x March 31, 2014

[FORM 10-Q (Mark One) x March 31, 2014 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC Nevada 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86- 898-6681-1730 (China) (Issuer's telephone number, including area code)] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: May 15, 2014 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qex321033114.htm]

By | 2016-03-28T19:39:39+00:00 May 15th, 2014|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments

CMCM [Cheetah Mobile] SC 13G: (Original Filing)

[Schedule 13G Forms CUSIP NO. 163075104 13G Page 2 of 6 Pages 1. NAME OF REPORTING PERSONS I.R.S IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) (None) 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* ¨ x (a) 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Singapore NUMBER OF]

By | 2016-03-30T06:37:19+00:00 May 15th, 2014|Categories: Chinese Stocks, CMCM, SEC Original|Tags: , , , , , |0 Comments

CMCM [Cheetah Mobile] SC 13G: Schedule 13G Forms CUSIP NO. 163075104 13G Page

[Schedule 13G Forms CUSIP NO. 163075104 13G Page 2 of 6 Pages 1. NAME OF REPORTING PERSONS I.R.S IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) (None) 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* ¨ x (a) 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Singapore NUMBER OF]

By | 2016-03-30T06:38:12+00:00 May 15th, 2014|Categories: Chinese Stocks, CMCM, Webplus ver|Tags: , , , , , |0 Comments

CMCM [Cheetah Mobile] SC 13G/A: (Original Filing)

[Schedule 13G Forms CUSIP NO. 163075104 13G Page 2 of 6 Pages 1. NAME OF REPORTING PERSONS I.R.S IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) (None) 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* ¨ x (a) 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Singapore NUMBER OF]

By | 2016-03-30T06:39:11+00:00 May 15th, 2014|Categories: Chinese Stocks, CMCM, SEC Original|Tags: , , , , , |0 Comments

CBAK [CHINA BAK BATTERY] NT 10-Q: (Original Filing)

[FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): CUSIP NUMBER [ For Period Ended: March 31, 2014 [ Transition Report on Form 10-K [ Transition Report on Form 20-F [ Transition Report on Form 11-K [ Transition Report on Form 10-Q [ Transition Report on Form N-SAR For the Transition Period Ended: Nothing in this form shall be construed to]

CBAK [CHINA BAK BATTERY] NT 10-Q: FORM 12b-25 NOTIFICATION OF LATE FILING (Check one):

[FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): CUSIP NUMBER [ For Period Ended: March 31, 2014 [ Transition Report on Form 10-K [ Transition Report on Form 20-F [ Transition Report on Form 11-K [ Transition Report on Form 10-Q [ Transition Report on Form N-SAR For the Transition Period Ended: Nothing in this form shall be construed to]

Skip to toolbar